CA Patent

CA2418656A1 — Proline derivatives and use thereof as drugs

Assigned to Tanabe Pharma Corp · Expires 2002-02-21 · 24y expired

What this patent protects

The invention aims at providing compounds which exhibit therapeutic effects through the inhibition of DPP-IV and are satisfactory as drugs. The inventio n has been accomplished by finding that .gamma.-substituted proline derivative s of the general formula (I) exhibit potent DPP-…

USPTO Abstract

The invention aims at providing compounds which exhibit therapeutic effects through the inhibition of DPP-IV and are satisfactory as drugs. The inventio n has been accomplished by finding that .gamma.-substituted proline derivative s of the general formula (I) exhibit potent DPP-IV inhibitory activities and improving the same in stability. [In the general formula, each symbol is as defined in the description.]

Drugs covered by this patent

Patent Metadata

Patent number
CA2418656A1
Jurisdiction
CA
Classification
—
Expires
2002-02-21
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.